JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF – Get Free Report) traded up 5.2% during trading on Thursday . The stock traded as high as $3.31 and last traded at $3.31. Approximately 476 shares traded hands during trading, a decline of 5% from the average session volume of 500 shares. The stock had previously closed at $3.1450.
JCR Pharmaceuticals Stock Performance
The stock’s 50 day moving average price is $3.68 and its two-hundred day moving average price is $4.12.
JCR Pharmaceuticals Company Profile
JCR Pharmaceuticals Co, Ltd. is a Japan-based biotechnology company specializing in the development, production and commercialization of plasma-derived products and regenerative medicine solutions. The company focuses on manufacturing high-purity plasma proteins, including human serum albumin, immunoglobulins and coagulation factors, to support a range of therapeutic applications in hematology, immunology and critical care settings.
In its plasma-derived business, JCR leverages state-of-the-art fractionation and purification processes to supply products such as intravenous immunoglobulin and albumin formulations.
Featured Articles
- Five stocks we like better than JCR Pharmaceuticals
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for JCR Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JCR Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
